ClinicalTrials.Veeva

Menu

Obstructive Sleep Apnea in Pulmonary Embolism

U

University of Gaziantep

Status

Completed

Conditions

Pulmonary Thromboembolism
Obstructive Sleep Apnea

Treatments

Other: polysomnography

Study type

Observational

Funder types

Other

Identifiers

NCT01580085
gantep gogus 1

Details and patient eligibility

About

Obstructive sleep apnea (OSA) is a clinical syndrome characterized by repetitive closure of the airway and frequent awakenings during sleep. Repeated episodes of hypoxia, decrease in intrathoracic pressure, increased venous return and venous stasis, damage to vascular wall may ensue. An increased tendency for coagulation has also been reported in OSA. Venous stasis, vascular endothelial activation and hypercoagulability are also known risk factors for thromboembolism. All of these pathophysiologic changes in OSA may predispose patients for the development of pulmonary embolism (PE) however there is limited data about role of thromboembolic events in OSA.

Enrollment

75 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All consecutive patients diagnosed with pulmonary embolism

Exclusion criteria

  • less than 18 years of age
  • any restrictive or obstructive lung disease

Trial design

75 participants in 2 patient groups

Pulmonary embolism
Description:
Patients who were diagnosed with pulmonary embolism
Treatment:
Other: polysomnography
control group
Description:
age and sex matched adults with osa and no thromboembolism
Treatment:
Other: polysomnography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems